Factory 99% Brimonidine Tartrate CAS 70359-46-5 Chemical Intermediate Brimonidine Tartrate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A427
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Brimonidine Tartrate
• CAS: 70359-46-5
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Reduction of Intraocular Pressure
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Brimonidine Tartrate
Appearance	White Powder
CAS NO.	70359-46-5
Molecular Formula	C15H16BrN5O6
Storage	Keep in a cool, dry, dark location

 

Brimonidine Tartrate, with the molecular formula C15H16BrN5O6, is a highly selective alpha-2 adrenergic receptor agonist. It is primarily used in ophthalmic preparations for its therapeutic effects on intraocular pressure.

 

 

1. Ophthalmic Drops: Brimonidine Tartrate is commonly formulated as eye drops for direct administration to the eye.
2. Chronic Treatment: It is prescribed for chronic treatment of conditions such as open-angle glaucoma and ocular hypertension.
3. Post-Laser Surgery: It is also used to manage intraocular pressure following laser trabeculoplasty or other anterior segment laser surgeries.

1. Reduction of Intraocular Pressure: By acting on alpha-2 adrenergic receptors in the eye, Brimonidine Tartrate reduces the production of aqueous humor and increases uveoscleral outflow, thereby lowering intraocular pressure.
2. Improved Patient Compliance: The eye drop formulation allows for easy and convenient use, which can improve patient compliance with treatment regimens.
3. Minimal Systemic Effects: Due to its minimal systemic absorption, Brimonidine Tartrate has limited effects on the cardiovascular and central nervous systems, making it a suitable choice for patients who may be intolerant to other intraocular pressure-lowering medications.